Literature DB >> 11882900

Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position.

Karin Reif1, Eric H Ekland, Lars Ohl, Hideki Nakano, Martin Lipp, Reinhold Förster, Jason G Cyster.   

Abstract

B lymphocytes re-circulate between B-cell-rich compartments (follicles or B zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells. Despite the importance of B--T-cell interactions for the induction of antibody responses, the mechanism causing B-cell movement to the T zone has not been defined. Here we show that antigen-engaged B cells have increased expression of CCR7, the receptor for the T-zone chemokines CCL19 and CCL21, and that they exhibit increased responsiveness to both chemoattractants. In mice lacking lymphoid CCL19 and CCL21 chemokines, or with B cells that lack CCR7, antigen engagement fails to cause movement to the T zone. Using retroviral-mediated gene transfer we demonstrate that increased expression of CCR7 is sufficient to direct B cells to the T zone. Reciprocally, overexpression of CXCR5, the receptor for the B-zone chemokine CXCL13, is sufficient to overcome antigen-induced B-cell movement to the T zone. These findings define the mechanism of B-cell relocalization in response to antigen, and establish that cell position in vivo can be determined by the balance of responsiveness to chemoattractants made in separate but adjacent zones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882900     DOI: 10.1038/416094a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  167 in total

Review 1.  Positioning the immune system: unexpected roles for alpha6-integrins.

Authors:  Gillian Borland; William Cushley
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

Review 2.  The influence of follicular migration on T-cell differentiation.

Authors:  Karen M Smith; James M Brewer; Allan Mci Mowat; Yacov Ron; Paul Garside
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

3.  Lymph node B lymphocyte trafficking is constrained by anatomy and highly dependent upon chemoattractant desensitization.

Authors:  Chung Park; Il-Young Hwang; Rajesh K Sinha; Olena Kamenyeva; Michael D Davis; John H Kehrl
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 4.  Follicular helper T cells in immunity and systemic autoimmunity.

Authors:  Joseph E Craft
Journal:  Nat Rev Rheumatol       Date:  2012-05-01       Impact factor: 20.543

Review 5.  T cells that promote B-Cell maturation in systemic autoimmunity.

Authors:  Jason S Weinstein; Sairy G Hernandez; Joe Craft
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

Review 6.  B cell follicles and antigen encounters of the third kind.

Authors:  Jason G Cyster
Journal:  Nat Immunol       Date:  2010-10-19       Impact factor: 25.606

Review 7.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 8.  Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses.

Authors:  João Pedro Pereira; Lisa M Kelly; Jason G Cyster
Journal:  Int Immunol       Date:  2010-06       Impact factor: 4.823

9.  Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.

Authors:  Shehnaz K Hussain; Nancy A Hessol; Alexandra M Levine; Elizabeth Crabb Breen; Kathryn Anastos; Mardge Cohen; Gypsyamber D'Souza; Deborah R Gustafson; Sylvia Silver; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

10.  Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7-/- mice.

Authors:  Sofia Olmos; Sabriya Stukes; Joel D Ernst
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.